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Skin of patients with severe generalized recessive dystrophic 
epidermolysis bullosa (SGRDEB) was studied by immuno-
electron microscopy and immunoblotting with antibodies to 
type VII collagen, a major structural component of anchor-
ing fibri ls. In normal skin, the protein was localized to the 
dermoepidermal junction zone below the basement mem-
brane and was extractable from the papillary dermis after 
artificial epidermolysis. In SGRDEB skin, neither immuno-
reactive material below the basement membrane nor identi-
T ype VII collagen is found in the subbasement mem-brane zone of several stratified epithelia, including skin [1 ,2]. It has been identified recently as a structural component of anchoring fibri ls [1,3 J and it is believed to be reponsible for the cross-banded "collagenous" 
pattern of these fibrils. The type VII collagen molecule has been 
characterized after isolation from amnion epithelium [4], epidermal 
carcinoma cell lines [5], and from human skin and fibroblasts [6]. 
Recently it was shown to be identical with the epidermolysis bullosa 
acquisita antigen [7,8) . Type VII collagen consists of three presum-
ably identical a-chains that contain an unusually large triple-helical 
domain and a large carboxy terminal globular peptide as well as a 
small aminoterminal globular domain. Each chain has a length of 
about 425 nm and a molecu lar mass of 250-300 kDa. Conse-
quently, the molecular mass of the whole type VII collagen mole-
cule is close to 106 Da. Two molecules aggregate to an antiparallel 
dimer with the carboxy terminal domains pointing outward. The 
dimers aggregate laterally to form the anchoring fibrils. Probably, 
the aminoterminal ends correspond to the central regions of the 
anchoring fibrils and the carboxy terminal globules interact with 
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fiable anchoring fibrils could be recognized and neither the 
tissue form nor the specific proteolytic fragments of type VII 
collagen were found in extracts of SGRDEB skin. Very low 
amounts of type VII collagen a-chains could be detected in 
cultures of SGRDEB-fibroblasts, whereas normal fibroblasts 
synthesized more of this collagen. These results suggest that a 
genetic defect in the correct synthesis, secretion, or in the 
molecular assembly of type VII collagen may underlie 
SGRDEB.] Invest DermatoI93:3-9, 1989 
other components by insertion of the anchoring fibrils into the 
basement membrane and into the anchoring plaques in papillary 
dermis [3,5]. 
We [9] and others [10,11] have determined by indirect immuno-
fluorescence that in skin of patients with severe generalized reces-
sive dystrophic epidermolysis bullosa (SGRDEB) (the mutilating 
Hallopeau-Siemens variant) type VII collagen cannot be stained 
with polyclollal antibodies to the collagenous or with monoclonal 
antibodies to the noncollagenous domains of the molecule, whereas 
this collagen can be demonstrated in skin in other less severe generic 
variants of EB [9-11], e.g., the dominant dystrophic and recessive 
dystrophic epidermolysis bullosa (EB) with lesions localized to dis-
tal extremities only. 
Earlier electron microscopic studies [12-15] have suggested a 
partial or total lack of anchoring fibrils in skin of patients with 
SGRDEB. Several groups have reported complete absence of an-
choring fibrils in nonblistered skin [12 -14] and Hashimoto et al 
[15] reported that the skin of some patients showed structurally 
normal anchoring fibrils although there was moderate to marked 
reduction of the number of fibrils in most patients. These data 
suggest that genetic heterogeneity may exist within this group of 
disorders, although the majority of evidence seems to indicate that 
absence of anchoring fibrils is a specific structural defect in the 
mutilating SGRDEB. To extend the early ultrastructural and recent 
immunohistochemical observations and to define the genetic defect 
we examined the anchoring fibrils in SGRDEB using specific anti-
bodies to identify the affected structures at a molecular level. 
MATERIALS AND METHODS 
Patients and Biopsy Material Four patients, from two families, 
with mutilating SGRDEB were examined. The ages of the pro-
bands were 32, 22, 20, and 14 years. None of the patients had 
received any medication immediately before or at the time of the 
study. Samples from clinically uninvolved, normal appearing, non-
scarred skin were obtained from excision biopsies or in connection 
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with corrective surgery of patients with SGRDEB. The biopsy site 
was the upper arm in all patients. Normal skin samples were ob-
tained from healthy age-matched probands. 
Antibodies to Type vn Collagen Polyclonal, affinity purified 
antibodies to the collagenous triple-helical domain of human type 
VII collagen were prepared and characterized as described pre-
viously [6] . In short, the antibodies recognized type VII collagen 
both in native and denatured conformation. The antigen used for 
immunization was the purified triple-helical domain and thus the 
antibodies do not react with the noncollagenous C-terminal globu-
lar domain. These antibodies did not cross-react with other compo-
nents of the basement membrane or the dermal connective tissue. 
Indirect ImmunoB.uorescence Indirect immunofluorescence 
staining of5-tLm cryosections was performed with type VII collagen 
antibodies described above. Control staining of the basement mem-
brane was done with monoclonal antibodies to type IV collagen 
[16]. These antibodies were a kind gift of Dr. B. Odermatt, Depart-
ment of Pathology, University Hospital of Zurich. The fluorescein 
isothiocyanate-Iabeled second antibodies were obtained from Da-
kopatts (Glostrup, Denmark). The staining procedure was as de-
scribed [17]. 
Immunoelectron Microscopy Preembedding staining was per-
formed using the peroxidase-anti(>eroxidase (PAP) technique as 
described by Holubar et al [18,19J or the procedure of en bloc 
staining with colloidal gold bound to protein A as described by 
Keene et al (3). Essentially, the skin was cut to sma1l1-mm3 pieces 
and after washing in phosphate-buffered saline (PBS) fixed in 1 % 
p-formaldehyde in PBS for 30 min at 4 ° C and washed again several 
times with PBS. An initial overnight incubation at 4 ° C with rabbit 
antibodies to type VII collagen was followed by incubations with 
appropriately diluted swine-antirabbit Ig and rabbit-PAP (Dako-
patts, Glostrup, Denmark) or with gold-labeled protein A. Each 
incubation was followed by extensive washing with PBS. In nega-
tive controls, incubation with antibodies to type VII collagen was 
omitted. After final washing with PBS and postfixation in 2.5% 
glutaraldehyde in cacodylate buffer for 4 h at room temperature, the 
specimens were stained with 1 % OsO •. Dehydration was achieved 
by increasing concentrations of acetone and embedding was done in 
araldite. 
Immunoblotting Extraction of dermis and epidermis was per-
formed after artificial epidermolysis with 1 M NaCI as described 
previously [6,20). From the patients' skin, the epidermis could be 
easily removed with forceps without prior treatment. In short, both 
skin layers were extracted separately with 400 ttl/cm2 of a buffer 
containing 8 M urea, 2% sodium dodecyl sulphate, 0.1 M dithioer-
ythrol, 50 mM Tris-HCI, pH 7.4, and a mixture of proteinase in-
hibitors. The extraction was for 1 min at 95 ° C. The size of the 
biopsies extracted was 0.5-1 cm2, from both normal and EB skin. 
For analysis, an extract of equal area of EB and normal skin was 
chosen. 
For immunoblotting [21], the samples were separated with poly-
acrylamide gel electrophoresis in sodium dodecyl sulfate (SDS-
PAGE) with 4.5-15% gradient gels (22), e1ectrotransferred to ni-
trocellulose filters, and reacted with the antibodies. The second 
antibody was peroxidase-labeled goat-antirabbit Ig (Kirkegaard & 
Perry, Gaithersburg, MD). 
Fibroblast Cultures Fibroblasts from two SGRDEB patients rep-
resenting two families (32 and 14 years old) and age-matched con-
trols were established using standard techniques. The cells were 
grown to confluency in Dulbecco's minimal essential medium with 
10% fetal calf serum, 50 ttg/ml ascorbic acid, and antibiotics before 
extraction for immunoblotting experiments as described elsewhere 
[6]. In short, confluent cell layers were washed with PBS and ex-
tracted with 1 mlj25 cm2 of the buffer described above for skin 
extraction. The extraction was 1 min at 95°C. After dialysis, the 
samples were used for immunoblotting. 
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RESULTS 
To confirm the diagnosis and specific staining pattern, the 
SGRDEB skin was first stained with antibodies to type VII and type 
IV collagen by indirect immunofluorescence. As shown in Figure 1, 
for the 14-year-old patient, type IV collagen always showed a linear 
staining of the dermoepidermal basement membrane and the cuta-
neous vessels as was seen in healthy controls, but antibodies to type 
VII collagen failed to stain the dermoepidermal junction zone in 
SGRDEB. 
The SGRDEB skin and age- and localization-matched normal 
skin had to be fixed very mildly to preserve antigenicity for immu-
noelectron microscopy. After reaction with antibodies to type VII 
collagen, a strong precipitate at the sublamina densa region of the 
dermoepidermal junction zone could be observed in control skin 
when the peroxidase technique was used (Fig 2a). The precipitate 
reached about 0.2 ttm into the papillary dermis. When staining 
with antibodies was followed by protein-A gold, decoration of an-
choring fibrils and anchoring plaques was seen (Fig 2d). With this 
method, because of low affinity of protein A to antibody, the con-
centration of gold particles on sections was rather low. They were 
always found to bind to anchoring fibrils, however, indicating a 
specific reaction. In negative controls, no peroxidase precipitate or 
gold particles could be found (Fig 2b,e). When clinically uninvolved 
SGRDEB skin was examined under the same conditions, no stain-
ing was observed with either method (Fig 2cJ). Some of the mor-
phologic details of the skin had been lost because of the mild fixa-
tion. It was evident, however, that no structurally intact anchoring 
fibrils could be seen below the lamina densa in the SGRDEB skin, 
whereas they were well recognized in negative controls of normal 
skin stained without the first antibody. In SGRDEB skin the lamina 
densa appeared thin, but the hemidesmosomes seemed unaffected. 
Extraction of the highly aggregated tissue form of type VII colla-
gen from skin can be achieved with strongly denaturing buffers and 
reducing agents as reported earlier (6). For efficient extraction of 
normal dermis, removal of epidermis with the NaCI-split skin tech-
nique [20] is necessary. In SGRDEB skin no such splitting was 
needed because the epidermis could be removed easily from freshly 
excised skin. Because of splitting below the lamina densa in 
SGRDEB and possible adherence of anchoring fibril-related struc-
tures to the epidermis, also epidermal extracts from all patients were 
analyzed. To avoid proteolytic degradation of the structural/ro-
teins of the dermoepidermal junction zone, all incubation an ex-
traction buffers contained a mixture of inhibitors of neutral protein-
ases. The efficiency of protein extraction from both normal and 
SGRDEB skin was very similar as determined by protein staining of 
the samples on SDS-PAGE (Fig 3). In immunoblots, the tissue form 
of type VII collagen [6] could be identified in control dermis ex-
tracts (Fig 3, lanes 2,3). When dermis of SGRDEB skin was ex-
tracted, no band corresponding to the tissue form (Fig 3, lanes 4 - 6) 
or to the specific type VII collagen fragments (Fig 3, lanes 1,11) 
could be found in skin of any of the four patients. The results of skin 
extracts from 3 patients are shown in Figure 3. The skin of the 
14-year-old patient was analyzed in a different set of experiments 
that yielded identical results (not shown). Epidermis extracts from 
normal or EB skin did not contain any immunoreactive protein (Fig 
3, lanes 7 - 10). 
Fibroblast cultures were established from two patients with 
SGRDEB and normal controls. The SGRDEB fibroblasts grew 
slowly but appeared morphologically normal. The cells were grown 
to confluency in the presence of ascorbic acid to enhance collagen 
synthesis and the confluent cultures were extracted with a strongly 
denaturing buffer containing proteinase inhibitors. Extracts from 
about 2 X 106 fibroblasts were analyzed by immunoblotting (Fig 4). 
Normal fibroblasts synthesized small amounts of type VII collagen 
that could be identified in immunoblots. The SGRDEB cells syn-
thesized clearly less immunoreactive material detectable by blot-
ting. No specific degradation fragments were observed. Because of 
the very low amounts of type VII collagen in cell cultures, a more 
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detailed analysis of the structure of the immunoreactive type VII 
collagen has not been possible. 
DISCUSSION 
A defect of anchoring fibrils in dystrophic EB has been a subject 
given to much speculation [12 - 15,23 - 25). There have been re-
ports of electron microscopically abnormal anchoring fibril struc-
tures in both rece sive [12 - 15] and dominant [23,24] forms. A 
rarefication or lack of anchoring fibrils has been found in lecessive 
variants, whereas disrupted fibrillar structures have been observed in 
dominant forms . There are variations, however, in the observations 
on the extent of the lack of anchoring fibrils in severe recessive 
dystrophic EB (12 - 15). The problem of different morphologic 
findings in patient'S skin is further complicated by the fact that a 
considerable variation in the density of anchoring fibrils in different 
regions of the normal integument has been found by morphometric 
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Figure 1. Indirect immunofluorescence of clinically uninvolved skin ofthe 
14-year-old SGRDEB patient. taining with antibodies to type IV collagen 
is shown in (a) and type VII collagen in (b) . Note the complete absence of 
staining in (b) . Normal control skin stained with antibodies to type VII 
collagen (e) shows a linear pattern at the dermoepidermal junction. 
analysis [26]. The heterogeneity of the findings is also emphasized 
by the fact that with immunofluorescence studies, novel antigens of 
the dermal basement membrane zone have been characterized that 
show abnormal expression in some patients with recessive dystro-
phic EB. The KF-l [27] and the 19-DEJ-l [28] antigens define 
lamina densa and lamina lucida epitopes, respectively, and AFt and 
AF2 [25J anchoring fibril-related antigens that are defective in some 
EB patients. Thus, it becomes clear that only the exact molecular 
identification of the affected structural components can lead to a 
reliable analysis of the different subgroups of a genetic disorder. 
When antibodies to type VII collagen were used as probes to 
visualiz~ the anchoring fibril , no staining with type VlI collagen 
antibodies could be seen at the dermoepidermaljunction zone in all 
examined patients with mutilating SGRDEB [9,10]. This collagen, 
howe~er, was present in other localized forms of recessive dys-
trophiC EB. Also the EB acquisita antigen, now known to be identi-
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Figure 2. Immunoelectron microscopy of normal and SGRDEB skin with 
polyclonal antibodies to type VII collagen staining with peroxidase method 
in (a - c) and with immunogold technique in (d - f). Note the heavy sublam-
ina densa immunoprecipitate in normal skin (a) and decoration with gold 
particles (arrows) of anchoring fibrils and an anchoring plaque (d) . In EB 
skin , no immunoprecipitates or gold labeling could be observed (eJ). In EB 
skin no anchoring fibrils could be identilied. Negative controls of normal 
skin stained without first antibody are shown in (b) and (e) . 
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Figure 3. Immunoblotting with antitype VII collagen antibodies. of de r.ma I and epidermal extracts from normal and SGROEB skin. Left pond: immunoblot; 
riglrt POIle!. correspondin~ SOS-PAGE. Lallf 1: standard, charac.tenSCIc triple-helical fragment of ~pe VII collagen. Thc arrowlread points to the triple-helical 
fragmcnt, molecular weight 170 kOa. Lanes 2,3: normal dermiS extract: The arrow P?lI1ts to the tissue form of type VII collagen, molecular weight close to 
300 kOa. LQlles 4 - 6: dermis extracts ~f the 32, 22, and 20-year-~ld pattents, respectl~ely . Lane 7: n?rmaI epidermis extract. Lalles 8 - 1 0: epidermis extracts 
from the 32, 22, and 20-year-old pattents. Lane 11 : standard as 111 lane t. The dots II1dlcate the migration positions of the collagenous molecular weight 
standards p, at, and a2 chains of type I collagen (from top to bottom). The apparent molecular weights are p: 200 kOA, at :95 kOa, and a2:87 kOa, however, 
collagens migrate anomalously slow on SOS-PAGE and about 20% should be added to the molecular weight when compared with globular standards. 
cal with type VII collagen, has been found to be present in skin from 
some patients with recessive dystrophic EB [29]. Very recently par-
tial staining with antibodies to the C-terminal noncollagenous do-
main of type VII collagen was reported in some patients with reces-
sive dystrophic EB [30]. In these two studies an exact clinical 
classification of the patients was not reported. 
With varying findings even with molecularly defined probes it 
now seems extremely important to emphasize the genetic heteroge-
neity of the dystrophic EB. The recessive variants can be clinically 
divided to at least three subgroups: the severe mutilating general-
ized variant, also called sublethal,. the localized variant with lesions 
mainly on distal extremities, and the inversa variant [31,32]. Direct 
biochemical and immunohistologic comparison of the different 
variants is not adequate, because they may represent distinct genetic 
defects. Therefore, to avoid confusion, when patients with recessive 
dystrophic EB are investigated it is impottant to report the exact 
clinical classification of the probands. Unfortunately, this has not 
always been the case and reliable comparison of the published data 
does not seem possible. In this study, all patients showed the mu.ti-
lating SGROEB with "mitten" hands and feet. Also other studies 
with monoclonal [to] and polyclonal [9] (J.-P. Ortonne, personal 
communication) antibodies in 22 patients with clinically well-char-
acterized mutilating SGROEB have demonstrated complete lack of 
type VII collagen staining, a finding that seems to define a group of 
patients with the most severe form of recessive dystrophic EB. 
The absence of staining could have several explanations: changed 
antigenic reactivity, masking of antigenic sites by other extracellu-
lar matrix components, or lack of the antigen. Trials to unmask 
antigenic sites with proteinase or acid treat~e~ts hav.e not revealed 
positive staining in our hands. Control stammgs with poly~lonal 
and monoclonal antibodies recognizing different structural epltopes 
of type VII collagen in native and denatured conformation invari-
ably detected the protein. In addition, type IV collagen, a molecule 
in close proximity to prospective anchoring fibrils was stained nor-
mally in normal and SGRDEB skin. 
Here, we could show with ultrastructural and biochemical 
me~hods t~at no in~ac~ type VII collagen was present in the skin of 4 
patients with mutilating SGRDEB. The question arises whether 
this absence is of primary or secondary nature, due to suppressed or 
faul~ synthesis or rather due to increased degradation. Bauer [33] 
has Isolated a mutant hyperactive collagenase from skin fibroblasts 
of some patients with severe recessive dystrophic EB. Therefore, 
type VII collagen in the anchoring fibrils may be degraded by this 
muta~t enzyme, a process that results in disrupted dermoepidermal 
coheSIOn and subepidermal blistering. The fact that neither im-
munolabeling with type VII collagen antibodies nor identifiable 
al~c~oring fi~rils could .be observed with electron microscope in 
chl1lcally ul1lnvolved Sk111 suggests that, in these patients, no stable 
anch.orin~ fibrils are asse.mbled. This is further supported by the fact 
that 111 skl11 extracts no tissue form or any specific fragments of type 
VII collagen could be detected . If the absence of type VII collagen in 
SGRDEB were explained by collagenase degradation alone, one 
would expect positive staining of the C-terminal noncollagenous, 
collagenase-resistant domain when monoclonal antibodies to the 
C-~erminal domain are used. This has been reported in some of the 
patients [29,30] but not all [10,11]. The possibility that degradation 
of the C-terminal domain might result from secondary proteolysis 
by tissue proteinases after the stable structures are attacked cannot be 
excluded at this point. Yet another explanation for the absence of 
type VII collagen staining would be synthesis of abnormal a-chains 
that cannot form stable functional suprastructures and that would be 
d.egraded by proteinases. Our finding that fibroblasts from 2 pa-
tients sy.ntheslze sn:all amounts of type VII collagen a-chains sup-
ports thiS hypotheSIS. However, we cannot make any conclusions 
about the primary structure of these chains at this point. Further 
biochemical analysis using protein chemistry as well as cDNA and 
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Figure 4. Immunoblot of normal and SGRDEB fibroblast extracts with 
antibodies to type VII collagen. Lalles 1,2: normal fibroblasts; lanes 3,4: 
fibroblasts from the 14-year-old patient; la'les 5,6: fibroblasts from the 32-
year-old patient. Equal quantities of cell extract were loaded in the slots. Lane 
7: standard type VII collagen fragments. The arrowhead points to the triple-
helical type VII collagen fragment and the arrows to the PI and P2 subfrag-
ments. On the left , the migration positions of collagenous molecular weight 
standards (see also Fig 3) are indicated. 
gene probes is necessary to elucidate the relation of the hyperactive 
collagenase and a type VII collagen defect at the level of protein and 
RNA synthesis and gene structure. 
Further interesting questions about molecular etiology of the 
different dystrophic EB remain open. In localized recessive and 
dominant EB variants, analogous subepidermal blisters are seen but 
type VII collagen seems to be £resent in a normal pattern at tpe 
dermoepidermal junction zone [9,10] . The question arises whether 
other structural components of anchoring fibrils exist that could be 
missing in these patients. Goldsmith and Briggaman [25] and Fine 
et al [27,28] have reported antibodies to anchoring fibril [25] or 
lamina densa [27] and lamina lucida [28] antigens, which show 
diminished staining in recessive dystrophic EB skin. Whether these 
antibodies react with other components or with type VII collagen 
remains unknown, but it would be fascinating to speculate that they 
recognize other structural proteins that interact with type VIl colla-
gen to form stable and functional anchoring fibrils. 
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